Close Menu

NEW YORK — The US Food and Drug Administration last week granted Emergency Use Authorization for saliva collection devices used for SARS-CoV-2 testing that was developed by DNA Genotek.

The ORAcollect RNA ORE-100 and ORAcollect RNA OR-100 devices are designed for the collection, stabilization, transport of saliva specimens suspected of containing SARS-CoV-2 RNA. They are intended for use as a component of a third-party SAR-CoV-2 test or home/self-collection kit and are not intended for sale directly to patients.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.

Sponsored by
Mission Bio

Recent work by many investigators has discovered that over the course of aging, hematopoietic stem cells (HSCs) commonly undergo clonal expansion.